Dimerix Ltd (DXB) - Total Assets
Based on the latest financial reports, Dimerix Ltd (DXB) holds total assets worth AU$91.18 Million AUD (≈ $64.51 Million USD) as of June 2025. Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments. Explore DXB operating cash to total liabilities to assess how comfortably operating cash covers total debt obligations.
Dimerix Ltd - Total Assets Trend (1989–2025)
This chart illustrates how Dimerix Ltd's total assets have evolved over time, based on quarterly financial data. See Dimerix Ltd shareholders equity for net asset value and shareholders' equity analysis.
Dimerix Ltd - Asset Composition Analysis
Current Asset Composition (June 2025)
Dimerix Ltd's total assets of AU$91.18 Million consist of 79.2% current assets and 20.8% non-current assets.
| Asset Category | Amount (AUD) | % of Total Assets |
|---|---|---|
| Cash & Equivalents | AU$68.28 Million | 74.9% |
| Accounts Receivable | AU$3.64 Million | 4.0% |
| Inventory | AU$0.00 | 0.0% |
| Property, Plant & Equipment | AU$117.64K | 0.1% |
| Intangible Assets | AU$0.00 | 0.0% |
| Goodwill | AU$0.00 | 0.0% |
Asset Composition Trend (1989–2025)
This chart illustrates how Dimerix Ltd's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution. For live market cap, price, and company overview, see Dimerix Ltd stock valuation.
Key Asset Composition Facts
- Current vs. Non-Current Assets: Dimerix Ltd's current assets represent 79.2% of total assets in 2025, an increase from 21.7% in 1989.
- Cash Position: Cash and equivalents constituted 74.9% of total assets in 2025, up from 1.2% in 1989.
- Tangible vs. Intangible: Intangible assets (including goodwill) make up 0.0% of total assets, unchanged from 0.0% in 1989.
- Asset Diversification: The largest asset category is cash and equivalents at 74.9% of total assets.
Dimerix Ltd Competitors by Total Assets
Key competitors of Dimerix Ltd based on total assets are shown below.
| Company | Country | Total Assets |
|---|---|---|
|
Ascendis Pharma AS
NASDAQ:ASND
|
USA | $2.01 Billion |
|
Halozyme Therapeutics Inc
NASDAQ:HALO
|
USA | $2.22 Billion |
|
Akero Therapeutics Inc
NASDAQ:AKRO
|
USA | $1.01 Billion |
|
Beijing Tiantan Biological Products Corp Ltd
SHG:600161
|
China | CN¥16.55 Billion |
|
Zealand Pharma A/S
CO:ZEAL
|
Denmark | Dkr16.46 Billion |
|
Verona Pharma PLC ADR
NASDAQ:VRNA
|
USA | $572.87 Million |
|
Immunitybio Inc
NASDAQ:IBRX
|
USA | $518.99 Million |
|
Tibet Cheezheng Tibetan Medicine Co Ltd
SHE:002287
|
China | CN¥6.66 Billion |
Dimerix Ltd - Liquidity and Working Capital Analysis
Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.
Key Liquidity Metrics
| Metric | Current | 1 Year Ago | 5 Years Ago |
|---|---|---|---|
| Current Ratio | 3.26 | 9.49 | 3.95 |
| Quick Ratio | 3.26 | 9.49 | 3.91 |
| Cash Ratio | 3.08 | 6.58 | 2.96 |
| Working Capital | AU$50.02 Million | AU$28.55 Million | AU$7.76 Million |
Dimerix Ltd - Advanced Valuation Insights
This section examines the relationship between Dimerix Ltd's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.
Key Valuation Metrics
| Current Price-to-Book Ratio | 22.44 |
| Latest Market Cap to Assets Ratio | 1.14 |
| Asset Growth Rate (YoY) | 184.2% |
| Total Assets | AU$91.18 Million |
| Market Capitalization | $104.08 Million USD |
Valuation Analysis
Above Book Valuation: The market values Dimerix Ltd's assets above their book value (1.14x), reflecting positive investor sentiment about the company's future prospects.
Rapid Asset Growth: Dimerix Ltd's assets grew by 184.2% over the past year, indicating significant expansion of the company's resource base.
Annual Total Assets for Dimerix Ltd (1989–2025)
The table below shows the annual total assets of Dimerix Ltd from 1989 to 2025.
| Year | Total Assets | Change |
|---|---|---|
| 2025-06-30 | AU$91.18 Million ≈ $64.51 Million |
+184.23% |
| 2024-06-30 | AU$32.08 Million ≈ $22.70 Million |
+80.65% |
| 2023-06-30 | AU$17.76 Million ≈ $12.56 Million |
+7.64% |
| 2022-06-30 | AU$16.50 Million ≈ $11.67 Million |
+75.11% |
| 2021-06-30 | AU$9.42 Million ≈ $6.67 Million |
-9.32% |
| 2020-06-30 | AU$10.39 Million ≈ $7.35 Million |
+110.28% |
| 2019-06-30 | AU$4.94 Million ≈ $3.50 Million |
-31.99% |
| 2018-06-30 | AU$7.26 Million ≈ $5.14 Million |
+152.97% |
| 2017-06-30 | AU$2.87 Million ≈ $2.03 Million |
+13.72% |
| 2016-06-30 | AU$2.53 Million ≈ $1.79 Million |
-14.94% |
| 2015-06-30 | AU$2.97 Million ≈ $2.10 Million |
+144.61% |
| 2014-06-30 | AU$1.21 Million ≈ $858.74K |
-31.13% |
| 2014-04-30 | AU$1.76 Million ≈ $1.25 Million |
+0.50% |
| 2013-06-30 | AU$1.75 Million ≈ $1.24 Million |
+44.40% |
| 2012-06-30 | AU$1.21 Million ≈ $859.19K |
-23.81% |
| 2011-06-30 | AU$1.59 Million ≈ $1.13 Million |
-0.79% |
| 2010-06-30 | AU$1.61 Million ≈ $1.14 Million |
+316.92% |
| 2009-06-30 | AU$385.33K ≈ $272.65K |
-84.26% |
| 2008-06-30 | AU$2.45 Million ≈ $1.73 Million |
-39.86% |
| 2007-06-30 | AU$4.07 Million ≈ $2.88 Million |
+34.01% |
| 2006-06-30 | AU$3.04 Million ≈ $2.15 Million |
-71.12% |
| 2005-06-30 | AU$10.52 Million ≈ $7.44 Million |
+475.65% |
| 2004-06-30 | AU$1.83 Million ≈ $1.29 Million |
+50.28% |
| 2003-06-30 | AU$1.22 Million ≈ $860.54K |
-35.67% |
| 2002-06-30 | AU$1.89 Million ≈ $1.34 Million |
-17.01% |
| 2001-06-30 | AU$2.28 Million ≈ $1.61 Million |
-71.17% |
| 2000-06-30 | AU$7.90 Million ≈ $5.59 Million |
-13.37% |
| 1999-06-30 | AU$9.12 Million ≈ $6.45 Million |
-5.86% |
| 1998-06-30 | AU$9.69 Million ≈ $6.86 Million |
+328.61% |
| 1997-06-30 | AU$2.26 Million ≈ $1.60 Million |
+0.77% |
| 1996-06-30 | AU$2.24 Million ≈ $1.59 Million |
+13.25% |
| 1995-06-30 | AU$1.98 Million ≈ $1.40 Million |
-2.56% |
| 1994-06-30 | AU$2.03 Million ≈ $1.44 Million |
+24.27% |
| 1993-06-30 | AU$1.64 Million ≈ $1.16 Million |
+40.91% |
| 1992-06-30 | AU$1.16 Million ≈ $821.48K |
+1.04% |
| 1991-06-30 | AU$1.15 Million ≈ $812.99K |
-33.47% |
| 1990-06-30 | AU$1.73 Million ≈ $1.22 Million |
-3.03% |
| 1989-06-30 | AU$1.78 Million ≈ $1.26 Million |
-- |
About Dimerix Ltd
Dimerix Limited, a biopharmaceutical company, develops and commercializes pharmaceutical products for unmet medical needs in Australia. It develops DMX-200 for the treatment of focal segmental glomerulosclerosis disease, diabetic kidney disease, and ARDS associated with COVID-19; and DMX-700 for orphan respiratory/renal disease, as well as proprietary Receptor-HIT assay technology. The company is… Read more